Skip to content

Gelweave™ 733032Recalls & reported problems

Vascutek Ltd · Gelweave Gelatin Impregnated Woven Vascular Prosthesis STRAIGHT · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05037881106878), received between Nov 25, 2020 and Jul 11, 2024 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Material Puncture/Hole” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Material Puncture/Hole1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • Thrombosis/Thrombus1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 11, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    CLINICAL STUDY: (B)(6). EVENT DATE: 27 NOV 2022. IMPLANT DATE: (B)(6) 2019. EVENT: ARTERIAL OR VENOUS THROMBOSIS WITH NO MEDICAL HISTORY. ON (B)(6) 2022 PATIENT WAS ADMITTED TO (B)(6) MEDICAL CENTER TO UNDERGO SURGICAL INTERVENTION FOR HER CARDIOTHORACIC DIAGNOSIS OF PARTIALLY THROMBOSED ASCENDING PSEUDOANEURYSM AND NEW 5.9CM EXTENT TYPE III TAAA. THE THROMBOSIS WAS LOCATED IN THE VESSEL. OVERALL, THE PATIENT TOLERATED THE PROCEDURE WELL WITHOUT SIGNIFICANT DIFFICULTY OR EVIDENT COMPLICATION, AND WAS TRANSFERRED TO THE CARDIOTHORACIC SURGICAL INTENSIVE CARE UNIT. IN THE IMMEDIATE POSTOPERATIVE PERIOD, SHE CONTINUED TO DO PROGRESS WELL. ULTIMATELY, SHE WAS TRANSFERRED TO THE STEP-DOWN UNIT FOR THE REMAINDER OF HER HOSPITAL COURSE. AFTER DISCUSSION WITH THE CASE MANAGER, PATIENT AND FAMILY; THE DECISION WAS MADE TO HAVE PATIENT DISCHARGE TO HOME (B)(6) 2022. THIS WAS AN UNANTICIPATED EVENT, MEDICATION & SURGICAL INTERVENTION WAS CARRIED OUT- TRANSCERVICAL RETROPHARYNGEAL CAROTID TO CAROTID TO SUBCLAVIAN BYPASS WAS PERFORMED. PATIENT OUTCOME: RESOLVED WITH SEQUELAE ON (B)(6) 2022. THIS REPORT IS BEING SUBMITTED AS A FOLLOW-UP FOR MANUFACTURING REPORT #9612515-2024-00047 TO PROVIDE EVE

    Patient problems: Thrombosis/Thrombus

    MAUDE report 19719135 ↗
  • MalfunctionNov 25, 2020Material Puncture/Hole; Material Puncture/Hole

    ON (B)(6) 2020 THE CLINICIAN HAD JUST IMPLANTED THE GELWEAVE GRAFT AND RELEASED THE CLAMP FORM THE AORTA, A SMALL 2MM TEAR WAS OBSERVED NEAR THE ANASTOMOSIS (2CM). THE TEAR WAS REPAIRED USING 5.0 PROLINE SUTURE. THE PROCEDURE WAS COMPLETED SUCCESSFULLY. THE EVENT WAS REPORTED AS DEVICE RELATED AND POSSIBLY PROCEDURAL RELATED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 10903463 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page